Maximiliano Vasquez

Person

Palo Alto, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
E. coli specific antibodies
- Patent number 12,103,962
- Issue date Oct 1, 2024
- X4 PHARMACEUTICALS (AUSTRIA) GMBH
- Eszter Nagy
- G01 - MEASURING TESTING
Information Patent Grant
Antibody libraries
- Patent number 12,018,403
- Issue date Jun 25, 2024
- Adimab, LLC
- Maximiliano Vasquez
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Highly potent antibodies binding to death receptor 5
- Patent number 11,891,446
- Issue date Feb 6, 2024
- Galaxy Biotech, LLC
- Kyung Jin Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD3-binding domains and antibodies comprising them, and method...
- Patent number 11,542,330
- Issue date Jan 3, 2023
- Adimab, LLC
- Laura M. Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
- Patent number 11,186,646
- Issue date Nov 30, 2021
- Five Prime Therapeutics, Inc.
- Justin Wong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of detecting TIM-3 using antibody molecules to TIM-3
- Patent number 11,155,620
- Issue date Oct 26, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Rationally designed, synthetic antibody libraries and uses therefor
- Patent number 11,008,568
- Issue date May 18, 2021
- Adimab, LLC
- Maximiliano Vasquez
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Rationally designed, synthetic antibody libraries and uses therefor
- Patent number 11,008,383
- Issue date May 18, 2021
- Adimab, LLC
- Maximiliano Vasquez
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 10,981,990
- Issue date Apr 20, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Grant
Highly potent antibodies binding to death receptor 4
- Patent number 10,941,204
- Issue date Mar 9, 2021
- Galaxy Biotech, LLC
- Kyung Jin Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody libraries
- Patent number 10,889,811
- Issue date Jan 12, 2021
- Adimab, LLC
- Maximiliano Vasquez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for purifying heterodimeric multispecific antibodies from p...
- Patent number 10,787,500
- Issue date Sep 29, 2020
- Adimab, LLC
- Juergen Hermann Nett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies to fibroblast growth factor receptor 2
- Patent number 10,689,448
- Issue date Jun 23, 2020
- Galaxy Biotech, LLC
- Kyung Jin Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
- Patent number 10,562,970
- Issue date Feb 18, 2020
- Five Prime Therapeutics, Inc.
- Justin Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 10,472,419
- Issue date Nov 12, 2019
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Rationally designed, synthetic antibody libraries and uses therefor
- Patent number 10,196,635
- Issue date Feb 5, 2019
- Adimab, LLC
- Maximiliano Vasquez
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Rationally designed, synthetic antibody libraries and uses therefor
- Patent number 10,189,894
- Issue date Jan 29, 2019
- Adimab, LLC
- Maximiliano Vasquez
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Monoclonal antibodies to fibroblast growth factor receptor 2
- Patent number 10,138,301
- Issue date Nov 27, 2018
- Galaxy Biotech, LLC
- Kyung Jin Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody libraries
- Patent number 10,138,478
- Issue date Nov 27, 2018
- Adimab, LLC
- Maximiliano Vasquez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
- Patent number 9,957,327
- Issue date May 1, 2018
- Five Prime Therapeutics, Inc.
- Justin Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Endoglin antibodies
- Patent number 9,944,714
- Issue date Apr 17, 2018
- Tracon Pharmaceuticals, Inc.
- Charles Theuer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 9,884,913
- Issue date Feb 6, 2018
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of detecting a tumor expressing fibroblast growth factor re...
- Patent number 9,834,609
- Issue date Dec 5, 2017
- Galaxy Biotech, LLC
- Kyung Jin Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
- Patent number 9,695,243
- Issue date Jul 4, 2017
- Five Prime Therapeutics, Inc.
- Justin Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 9,605,070
- Issue date Mar 28, 2017
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Endoglin antibodies
- Patent number 9,518,122
- Issue date Dec 13, 2016
- Tracon Pharmaceuticals, Inc.
- Charles Theuer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies to fibroblast growth factor receptor 2
- Patent number 9,382,324
- Issue date Jul 5, 2016
- Galaxy Biotech, LLC
- Kyung Jin Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody libraries
- Patent number 9,354,228
- Issue date May 31, 2016
- Adimab, LLC
- Maximiliano Vasquez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding antibodies that bind colony stimulating fact...
- Patent number 9,200,075
- Issue date Dec 1, 2015
- Five Prime Therapeutics, Inc.
- Justin Wong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Endoglin antibodies
- Patent number 9,150,652
- Issue date Oct 6, 2015
- Tracon Pharmaceuticals, Inc.
- Charles Theuer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
- Publication number 20250213684
- Publication date Jul 3, 2025
- Novartis AG
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY LIBRARIES
- Publication number 20250154687
- Publication date May 15, 2025
- ADIMAB, LLC
- Maximiliano Vasquez
- G01 - MEASURING TESTING
Information Patent Application
SYSTEMS AND METHODS FOR INTELLIGENT CONSTRUCTION OF ANTIBODY LIBRARIES
- Publication number 20250125011
- Publication date Apr 17, 2025
- ADIMAB, LLC
- Tushar Jain
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR
- Publication number 20230399386
- Publication date Dec 14, 2023
- ADIMAB, LLC
- Maximiliano Vasquez
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR
- Publication number 20230348901
- Publication date Nov 2, 2023
- ADIMAB, LLC
- Maximiliano Vasquez
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2
- Publication number 20230242650
- Publication date Aug 3, 2023
- Galaxy Biotech, LLC
- Kyung Jin Kim
- G01 - MEASURING TESTING
Information Patent Application
ANTI-CD3-BINDING DOMAINS AND ANTIBODIES COMPRISING THEM, AND METHOD...
- Publication number 20230151097
- Publication date May 18, 2023
- ADIMAB LLC
- Laura M. Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FC VARIANTS WITH REDUCED EFFECTOR FUNCTION
- Publication number 20220396622
- Publication date Dec 15, 2022
- ADIMAB, LLC
- Robert Pejchal
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220185883
- Publication date Jun 16, 2022
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Application
Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)
- Publication number 20220153851
- Publication date May 19, 2022
- Five Prime Therapeutics, Inc.
- Justin Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220133889
- Publication date May 5, 2022
- Novartis AG
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY POTENT ANTIBODIES BINDING TO DEATH RECEPTOR 4 AND DEATH RECE...
- Publication number 20210238297
- Publication date Aug 5, 2021
- Galaxy Biotech, LLC
- Kyung Jin Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY LIBRARIES
- Publication number 20210130813
- Publication date May 6, 2021
- ADIMAB, LLC
- Maximiliano Vasquez
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FC VARIANTS WITH REDUCED EFFECTOR FUNCTION
- Publication number 20210087271
- Publication date Mar 25, 2021
- ADIMAB, LLC
- Robert Pejchal
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM P...
- Publication number 20210047387
- Publication date Feb 18, 2021
- ADIMAB, LLC
- Juergen Hermann Nett
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2
- Publication number 20200347141
- Publication date Nov 5, 2020
- Galaxy Biotech, LLC
- Kyung Jin Kim
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200308277
- Publication date Oct 1, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)
- Publication number 20200223931
- Publication date Jul 16, 2020
- Five Prime Therapeutics, Inc.
- Justin Wong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200223917
- Publication date Jul 16, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD3-BINDING DOMAINS AND ANTIBODIES COMPRISING THEM, AND METHOD...
- Publication number 20200190189
- Publication date Jun 18, 2020
- ADIMAB, LLC
- Laura M. Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Endoglin Antibodies
- Publication number 20200048360
- Publication date Feb 13, 2020
- Tracon Pharmaceuticals, Inc.
- Charles P. Theuer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGHLY POTENT MONOCLONAL ANTIBODIES TO ANGIOGENIC FACTORS
- Publication number 20190352386
- Publication date Nov 21, 2019
- Kyung Jin Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR
- Publication number 20190225677
- Publication date Jul 25, 2019
- ADIMAB, LLC
- Maximiliano Vasquez
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR
- Publication number 20190203205
- Publication date Jul 4, 2019
- ADIMAB, LLC
- Maximiliano Vasquez
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2
- Publication number 20190153105
- Publication date May 23, 2019
- Galaxy Biotech, LLC
- Kyung Jin Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGHLY POTENT ANTIBODIES BINDING TO DEATH RECEPTOR 4 AND DEATH RECE...
- Publication number 20190062443
- Publication date Feb 28, 2019
- Galaxy Biotech, LLC
- Kyung Jin Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY LIBRARIES
- Publication number 20180371454
- Publication date Dec 27, 2018
- ADIMAB, LLC
- Maximiliano Vasquez
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R)
- Publication number 20180215830
- Publication date Aug 2, 2018
- Five Prime Therapeutics, Inc.
- Justin Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
- Publication number 20180207273
- Publication date Jul 26, 2018
- Novartis AG
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Endoglin Antibodies
- Publication number 20180194854
- Publication date Jul 12, 2018
- Tracon Pharmaceuticals, Inc.
- Charles P. Theuer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Maximiliano Vasquez

Person

Patents Grantslast 30 patents

E. coli specific antibodies

Antibody libraries

Highly potent antibodies binding to death receptor 5

Anti-CD3-binding domains and antibodies comprising them, and method...

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Method of detecting TIM-3 using antibody molecules to TIM-3

Rationally designed, synthetic antibody libraries and uses therefor

Rationally designed, synthetic antibody libraries and uses therefor

Antibody molecules to TIM-3 and uses thereof

Highly potent antibodies binding to death receptor 4

Antibody libraries

Methods for purifying heterodimeric multispecific antibodies from p...

Monoclonal antibodies to fibroblast growth factor receptor 2

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Antibody molecules to TIM-3 and uses thereof

Rationally designed, synthetic antibody libraries and uses therefor

Rationally designed, synthetic antibody libraries and uses therefor

Monoclonal antibodies to fibroblast growth factor receptor 2

Antibody libraries

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Endoglin antibodies

Antibody molecules to TIM-3 and uses thereof

Methods of detecting a tumor expressing fibroblast growth factor re...

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Antibody molecules to TIM-3 and uses thereof

Endoglin antibodies

Monoclonal antibodies to fibroblast growth factor receptor 2

Antibody libraries

Nucleic acids encoding antibodies that bind colony stimulating fact...

Endoglin antibodies

Patents Applicationslast 30 patents

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

ANTIBODY LIBRARIES

SYSTEMS AND METHODS FOR INTELLIGENT CONSTRUCTION OF ANTIBODY LIBRARIES

RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR

RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR

MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2

ANTI-CD3-BINDING DOMAINS AND ANTIBODIES COMPRISING THEM, AND METHOD...

FC VARIANTS WITH REDUCED EFFECTOR FUNCTION

METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3

Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

HIGHLY POTENT ANTIBODIES BINDING TO DEATH RECEPTOR 4 AND DEATH RECE...

ANTIBODY LIBRARIES

FC VARIANTS WITH REDUCED EFFECTOR FUNCTION

METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM P...

MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

ANTI-CD3-BINDING DOMAINS AND ANTIBODIES COMPRISING THEM, AND METHOD...

Endoglin Antibodies

HIGHLY POTENT MONOCLONAL ANTIBODIES TO ANGIOGENIC FACTORS

RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR

RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR

MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2

HIGHLY POTENT ANTIBODIES BINDING TO DEATH RECEPTOR 4 AND DEATH RECE...

ANTIBODY LIBRARIES

ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R)

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

Endoglin Antibodies